Ascendis Pharma (ASND) said the FDA has accepted its supplemental application for TransCon hGH for the treatment of adult growth hormone deficiency. Read more here.
Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources ...
OPKO Health’s weekly growth hormone injection could be approvable in adults without need for further clinical trials, the company has told pharmaphorum. The biotech has worked with Pfizer to co ...
Growth hormone deficiency that starts during childhood ... to form a solution that you give yourself as a subcutaneous injection. It’s available as a cartridge that’s attached to a reusable ...